Accuray (ARAY) Financials: History & Chart

Accuray Incorporated(ARAY)

Medical - Devices · Madison, WI

$0.30+0.02 (+7.37%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Accuray Incorporated

Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy. This system is employed to target both primary and metastatic tumors located outside the brain, specifically addressing areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate. They also provide the TomoTherapy System, which encompasses the Radixact System, designed to deliver highly precise radiation treatments (up to 50 patients daily) through integrated planning, delivery, and data management capabilities. Complementing these are the iDMS data management system and the Accuray precision treatment planning system, both offering comprehensive solutions for treatment planning and data handling. In addition to their technology, Accuray offers crucial post-sale services, including customer support, system installation, training, and various other professional services. The company primarily engages directly with its clientele, which includes hospitals and specialized treatment centers, through its dedicated sales force. In the United States, they also leverage sales agents and group purchasing organizations, while internationally, their reach extends through distributors and sales agents. Established in 1990, Accuray Incorporated maintains its corporate headquarters in Madison, Wisconsin.

Madison, WI

809 employees

www.accuray.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Stephen R. LaNeve

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	401.95M	100.92M	104.84M	102.24M	93.94M	127.54M	113.24M	116.17M	101.55M
Cost of Goods Sold	290.49M	65.38M	79.55M	78.17M	67.39M	88.56M	81.62M	74.28M	67.08M
Gross Profit	111.45M	35.54M	25.29M	24.07M	26.55M	38.98M	31.63M	41.89M	34.47M
Gross Profit Margin	27.7%	35.2%	24.1%	23.5%	28.3%	30.6%	27.9%	36.1%	33.9%
Total Operating Expenses	137.90M	42.63M	27.84M	29.56M	37.86M	34.74M	30.58M	37.19M	36.62M
Research & Development	37.75M	7.56M	8.18M	10.65M	11.37M	11.47M	10.71M	13.64M	12.12M
Selling, General & Administrative	83.97M	18.90M	19.66M	18.91M	26.49M	23.27M	19.87M	23.54M	24.50M
Operating Income (EBIT)	-26.44M	-7.09M	-2.55M	-5.49M	-11.31M	4.23M	1.05M	4.71M	-2.15M
Operating Margin	-6.6%	-7.0%	-2.4%	-5.4%	-12.0%	3.3%	0.9%	4.1%	-2.1%
Income Before Tax (EBT)	-47.25M	-1.51M	-11.34M	-13.20M	-21.21M	2.07M	-840K	3.23M	-3.33M
Interest Income	N/A	-453K	181K	N/A	272K	289K	278K	278K	N/A
Interest Expense	35.31M	11.10M	8.45M	7.71M	8.05M	4.23M	14.57M	2.88M	2.96M
Other Income/Expense	-20.81M	5.58M	-8.79M	-7.71M	-9.89M	-2.16M	-1.89M	-1.48M	-1.18M
Net Income	-49.19M	-1.94M	-11.80M	-13.77M	-21.68M	1.12M	-1.30M	2.54M	-3.95M
Income Tax Expense	1.95M	434K	468K	573K	471K	948K	457K	695K	625K
Net Profit Margin	-12.2%	-1.9%	-11.3%	-13.5%	-23.1%	0.9%	-1.1%	2.2%	-3.9%
EBITDA	-17.30M	-5.07M	-470K	-3.33M	-8.43M	5.83M	2.62M	6.22M	-685K
EBITDA Margin	-4.3%	-5.0%	-0.4%	-3.3%	-9.0%	4.6%	2.3%	5.4%	-0.7%
Depreciation & Amortization	9.14M	2.02M	2.08M	2.16M	2.88M	1.60M	1.57M	1.51M	1.46M
EPS Basic	-0.40	-0.02	-0.09	-0.11	-0.18	0.01	-0.01	0.03	-0.04
EPS Diluted	-0.40	-0.02	-0.09	-0.11	-0.18	0.01	-0.01	0.02	-0.04
Weighted Average Basic Shares	122.64M	122.64M	124.30M	119.97M	118.95M	106.70M	102.83M	101.41M	100.22M
Weighted Average Diluted Shares	122.64M	122.64M	124.30M	119.97M	118.95M	108.89M	102.83M	103.75M	100.22M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	06/30/2026	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021	06/30/2020	06/30/2019
Revenue	401.95M	458.50M	446.55M	447.61M	429.91M	396.29M	382.93M	418.79M
Cost of Goods Sold	290.49M	311.54M	303.63M	293.64M	269.95M	236.78M	233.21M	256.13M
Gross Profit	111.45M	146.97M	142.92M	153.96M	159.96M	159.51M	149.72M	162.65M
Gross Profit Margin	27.7%	32.1%	32.0%	34.4%	37.2%	40.3%	39.1%	38.8%
Total Operating Expenses	137.90M	139.13M	142.42M	151.58M	151.81M	137.27M	137.18M	162.07M
Research & Development	37.75M	47.94M	49.73M	57.13M	57.75M	52.73M	49.78M	56.49M
Selling, General & Administrative	83.97M	91.19M	92.69M	94.45M	94.06M	84.54M	87.40M	105.58M
Operating Income (EBIT)	-26.44M	7.84M	504K	2.38M	8.15M	22.23M	12.54M	-9.91M
Operating Margin	-6.6%	1.7%	0.1%	0.5%	1.9%	5.6%	3.3%	-2.4%
Income Before Tax (EBT)	-47.25M	1.13M	-11.82M	-6.79M	-2.00M	-4.56M	5.69M	-14.34M
Interest Income	N/A	1.19M	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	35.31M	12.95M	11.62M	10.63M	8.13M	16.89M	18.08M	15.08M
Other Income/Expense	-20.81M	-6.71M	-12.32M	-9.17M	-10.15M	-26.79M	-6.85M	-14.93M
Net Income	-49.19M	-1.59M	-15.54M	-9.28M	-5.35M	-6.31M	3.83M	-16.43M
Income Tax Expense	1.95M	2.73M	3.73M	2.49M	3.35M	1.75M	1.86M	2.09M
Net Profit Margin	-12.2%	-0.3%	-3.5%	-2.1%	-1.2%	-1.6%	1.0%	-3.9%
EBITDA	-18.50M	13.99M	6.41M	6.91M	13.66M	28.62M	20.08M	583K
EBITDA Margin	-4.6%	3.1%	1.4%	1.5%	3.2%	7.2%	5.2%	0.1%
Depreciation & Amortization	7.94M	6.15M	5.91M	4.53M	5.51M	6.39M	7.54M	10.49M
EPS Basic	-0.40	-0.02	-0.16	-0.10	-0.06	-0.07	0.04	-0.19
EPS Diluted	-0.40	-0.02	-0.16	-0.10	-0.06	-0.07	0.04	-0.19
Weighted Average Basic Shares	122.64M	102.77M	98.27M	94.88M	92.09M	92.03M	89.87M	87.47M
Weighted Average Diluted Shares	122.64M	102.77M	98.27M	94.88M	92.09M	92.03M	90.62M	87.47M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.